Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Intra-Cellular Therapies Inc. (ITCI) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intra-Cellular Therapies Inc. (ITCI) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for November 11th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 11th:
Fulgent Genetics, Inc. (FLGT - Free Report) : This genetic testing services provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 80% over the last 60 days.
FULGENT GENETIC Price and Consensus
FULGENT GENETIC price-consensus-chart | FULGENT GENETIC Quote
Fulgent Genetics’ shares gained 43.4% over the last one month more than S&P 500’s gain of 4.4%. The company possesses a Momentum Score of A.
FULGENT GENETIC Price
FULGENT GENETIC price | FULGENT GENETIC Quote
Luna Innovations Incorporated (LUNA - Free Report) : This manufacturer of fiber optic sensing, and test and measurement products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.
Luna Innovations Incorporated Price and Consensus
Luna Innovations Incorporated price-consensus-chart | Luna Innovations Incorporated Quote
Luna Innovations’s shares gained 18.2% over the last one month. The company possesses a Momentum Score of A.
Luna Innovations Incorporated Price
Luna Innovations Incorporated price | Luna Innovations Incorporated Quote
Intra-Cellular Therapies, Inc. (ITCI - Free Report) ): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.9% over the last 60 days.
Intra-Cellular Therapies Inc. Price and Consensus
Intra-Cellular Therapies Inc. price-consensus-chart | Intra-Cellular Therapies Inc. Quote
Intra-Cellular Therapies’ shares gained 23.1% over the last one month. The company possesses a Momentum Score of A.
Intra-Cellular Therapies Inc. Price
Intra-Cellular Therapies Inc. price | Intra-Cellular Therapies Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>